It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Some features of ATS will be disabled while you continue to use an ad-blocker.
(visit the link for the full news article)
Scientists Carole Lartigue and colleagues from the J. Craig Venter Institute in Rockville, Maryland, have published their results in a recent issue of Science. In addition to being a proof-of-concept experiment, the researchers hope that genome transplantation will enable the production of synthetic microbes for green energy sources, pharmaceuticals, chemicals and textiles.
The scientists’ results show that it is possible to transplant the complete set of DNA—the genome—from one species...
Originally posted by DaRAGE
So could it be used for instance...
Turning a male, into a female? lol I'm sure the bunch of hypnotists i chat with would love that. lol.
Or... Turning a human into a sheep?
Originally posted by intrepid
OK this isn't my field but do you think this could be used to change cancer cells back to health ones?
Originally posted by Griff
This has huge implications for the theory of evolution. We now know that changing the genome of something actually changes it to something else. Interesting.
Originally posted by Muaddib
this technology could be used to convert cancer cells into healthy cells, diseased skin, or burned skin could be made healthy again, etc.
[edit on 17-8-2007 by Muaddib]
In Finding a Way to Create Cancer, Hope for New Test
sing a precise molecular recipe, scientists have succeeded in turning normal human cells into cancer cells in the laboratory, a task that sounded simple but which eluded molecular biologists for more than 15 years.
In the end, what was required was just three genes. One pushed cells to grow unrelentingly, one inactivated signals for cells to stop growing and the third released a brake on the cells' life span.
Cancer Genome Scientists Discover 100 More Mutated Genes
Major study finding offers clues to a cure.
SOURCES: Len Lichtenfeld, M.D., deputy chief medical officer, American Cancer Society, Atlanta; March 6, 2007, Nature news teleconference with Andrew Futreal, Ph.D., and Michael Stratton, Ph.D., co-leaders, Cancer Genome Project, Wellcome Trust Sanger Institute, Cambridge, England)
WEDNESDAY, March 7 (HealthDay News) -- Cancer is a disease of genes gone awry, but new insights into the "cancer genome" could point the way to effective treatments, an international team of researchers reports.
Scientists taking part in the Cancer Genome Project say they've identified more than 100 mutated genes that help drive 210 different cancer types.
Each mutation could prove a promising new target for drug research, the scientists say.
"Looking at this set of genes may actually provide clues as to what is causing cancer and to also provide opportunities to think about developing therapeutic strategies against it," said the project's co-leader, Andrew Futreal of the Wellcome Trust Sanger Institute in Cambridge, England.
He and team co-leader Michael Stratton, also of the Wellcome Trust Sanger Institute, spoke to reporters at a special press conference Tuesday on the findings. The findings were expected to be published in the March 8 issue of the journal Nature.
According to the researchers, scientists have already uncovered about 350 cancer genes over the past few decades, usually through laborious single-gene experiments that took a long time to complete.
NIH Launches Cancer Genome Project
Genetic Mapping Could Revolutionize Treatment and Prevention, Health Officials Say
By Rick Weiss
Washington Post Staff Writer
Wednesday, December 14, 2005; Page A14
Federal health officials yesterday launched the biggest genetic research endeavor since the landmark human genome project: an ambitious effort to categorize all of the hundreds of molecular glitches that turn normal healthy cells into cancers.
The Cancer Genome Atlas, whose total cost could reach $1 billion or more, will for the first time direct the full force of today's sophisticated genetic technologies to the thorough understanding of a single disease -- one that will eventually strike nearly half of all Americans alive.